ended 31 March 2018 (1st quarter of 2018) as follows: Unit :Million Baht Q1/17 Q4/17 Q1/18 Change +/(-) QoQ % YoY % Net Revenue 215.83 191.39 206.12 14.73 7.70 -9.71 -4.50 Cost of Goods Sold 187.58 180.66
well as attending Chinese fertility centers which is the main user group of the subsidiary company. The Company reported Cost of Hospital Operations (including Depreciation and Amortization) of THB
, which came from costs of sales, distribution costs and administrative expenses control, Change in recognition of depreciation of right-of- use asset pursuant Thai Financial Reporting Standards No. 16
Operating Results of the Company in Q2/2020 Q2/18 Q2/19 1H/18 1H/19 Change +/(-) (THB million) YoY 1H Operating Revenue 312 144 (54%) 599 363 (39%) Gross Profit 201 79 (61%) 389 216 (44%) EBITDA 95 27 (72
period ended June 30, 2020 with details as follow; unit: million baht Items Q2/2019 Q2/2020 Changes Amount % Amount % Amount % Revenue from sales of goods 87.61 100.00 118.75 100.00 31.14 35.54 Cost of
: Statement of comprehensive income for the nine-month period ended 30 September (Unit : Million Baht) 2017 2016 Change Operating revenue 1,111.90 1,057.78 54.11 Operating cost 941.45 914.88 26.57 Gross profit
in order to increase sales, in the meantime focus on control system and reduce expenses to conform actual incomes which decreased. Performance Analysis Unit : MB For the quarterly Change For the six
Unit : MB For the period ended Change 31 March 2020 31 March 2019 MB % Net sales 195.84 238.99 (43.15) (18.06) Revenue from services 2.05 - 2.05 100.00 Other income 10.32 9.49 0.83 8.77 Total revenues
31, 2021, which can be summarized as follows: 1) Profit & Loss Analysis : Q1 2021 (Unit : Million Baht unless otherwise stated) Q1 2021 Q1 2020 Change Amount % Change Total Revenues 5,739 5,208 532